T80.59
Anaphylactic reaction due to other serum
Clinical Classification Guidelines
Medical Intelligence & Overview
An anaphylactic reaction is a severe, potentially life-threatening allergic response that occurs rapidly after exposure to an allergen. When such reactions are caused by the introduction of serum — a protein-rich fluid used in medical treatments — they are classified under ICD-10 code T80.59. This code specifically addresses anaphylactic responses triggered by serums other than those explicitly listed elsewhere. Recognizing and understanding this condition is important for timely management and prevention of future reactions.
Causes & Symptoms
Clinical Causes: Use of certain therapeutic serums, such as antivenoms or immunoglobulin treatments Administration of serum derived from animal sources, like horse or rabbit serum Introduction of serum used in diagnostic tests or vaccination procedures Exposure to specialty serums prepared for specific medical conditions
Key Symptoms: Rapid onset of difficulty breathing or shortness of breath Swelling of the face, lips, tongue, or throat Hives or widespread skin rash Feeling of tightness in the chest Dizziness or fainting Nausea, vomiting, or abdominal cramps A sudden drop in blood pressure, leading to weakness or loss of consciousness Anxiety or a sense of impending doom
Diagnostic & Treatment
Diagnosis Path: Diagnosis usually involves clinical assessment based on the recent administration of serum and present symptoms. Healthcare providers may perform physical examinations and monitor vital signs. Blood tests are not diagnostic, but may be used to rule out other causes of symptoms or to check for elevated levels of mediators like tryptase. Documentation of serum exposure events is crucial. In certain cases, allergy testing might be performed to identify specific sensitivities, but this is generally not recommended immediately after an anaphylactic event due to safety concerns.
Treatment Protocols: Immediate management is critical and typically involves the following steps: - Administering intramuscular epinephrine promptly to counteract severe allergic symptoms - Providing supplemental oxygen to assist with breathing - Monitoring and maintaining airway patency - Administering antihistamines and corticosteroids to reduce allergic response and prevent recurrence - Using intravenous fluids to manage blood pressure and dehydration - Ensuring continuous observation until symptoms resolve Post-event, healthcare providers may evaluate the patient's allergy history and consider alternative treatments to prevent future reactions. Patients are often advised to carry emergency epinephrine auto-injectors and to inform future medical staff about their serum allergy history.
Clinical Advice & FAQs
Billing Guidance
Is T80.59 a billable ICD-10 code?
Yes, T80.59 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report T80.59?
Clinical documentation must specify the nature of Anaphylactic reaction due to other serum and any associated comorbidities for accurate reporting.
Cite this Clinical Reference